Navigation Links
First Ultrasound Thrombolysis in U.S. Performed at Emory University Hospital

Physicians at Emory University Hospital recently performed for the first time in the United States a procedure called Ultrasound Assisted Thrombolysis to destroy a deadly blood clot in a patient suffering from deep vein thrombosis.

The procedure was performed by Abbas Chamsuddin, MD, associate professor of interventional radiology in the Emory University School of Medicine, to relieve a major system of clotting that filled the veins of the patient's leg, pelvis and inferior vena cava leading up to the heart.

Deep vein thrombosis (DVT) is a blood clot in a deep vein, usually found in the legs. These clots can, in turn, form in superficial veins in deep veins. While blood clots in superficial veins rarely cause serious problems, clots in deep veins (deep vein thrombosis) require immediate medical care.

According to Dr. Chamsuddin, ultrasound assisted thrombolysis incorporates use of a tiny catheter that houses an ultrasound wire and medications which slowly dissolve the clots.

"Ultrasound assisted thrombolysis uses a catheter that houses an ultrasound wire which causes fragmentation of the clot, while dripping clot busting medications are then delivered," says Dr. Chamsuddin."

The catheter-based drug delivery system combines the use of targeted drug delivery catheters and the therapeutic benefits of a high frequency low power ultrasound. The incorporation of ultrasound, says Dr. Chamsuddin, allows physicians to loosen tightly knit fabrics found within a blood clot called fibrin.

"The ultrasound helps temporarily loosen and separate the fibrin for more blood clot permeability," explains Dr. Chamsuddin. "The loosened fibrins then allow for reception of the infusion of clot-busting medications, which then slowly dissolve the blockage - usually within two to three days."

Emory houses two of the machines that are used for this procedure (called Peripheral Infusion Systems). < br>
Other treatments for deep vein clots typically include use of blood thinners such as heparin and warfarin. Heparin is given through a vein (intravenously, or IV) or as an injection. Warfarin is given as a pill. Treatment usually involves taking blood thinners for at least three months to prevent existing clots from growing.


'"/>




Related medicine news :

1. First Vaccine Designed for Africa Cleared for Testing in Humans
2. Ajanta Launches Worlds First Once-A-Day Nimesulide Oral Formulation
3. First human clone is near
4. First Artificial Heart patient has Major setback
5. First head-to-head trials of once weekly Fosamax and Actonel therapies
6. WHO Declares Vietnam First Country to Control SARS
7. Russia Reports First SARS Case
8. Hope for First New Melanoma Treatment in Decades
9. First global SARS meet opens
10. Stanford Medical Center Implements The First Virtual Cardiac Ultrasound
11. Hyderabad To Have Asia’s First Catheter Making Uni
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... ... October 13, 2017 , ... ... Arkansas that offers insurance and financial preparation services, is providing an update on ... Rescue organization. , Rock City Rescue is a locally recognized nonprofit that provides ...
(Date:10/13/2017)... Pa. (PRWEB) , ... October 13, 2017 , ... While ... dark poses a problem. Fortunately, an inventor from Austin, Texas, has identified a solution. ... to medication in darkness or restricted lighting. As such, it eliminates the need to ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... process to promote standards of excellence for the field of eating disorders, announces ... 22 – 25, 2018 in Orlando, Florida at the Omni Resort at ChampionsGate. ...
(Date:10/13/2017)... EDWARDSVILLE, Ill. (PRWEB) , ... ... ... University Edwardsville School of Pharmacy (SOP) alumni Hannah Randall, PharmD ‘17, and ... educated healthcare professionals on guideline updates for the primary prevention of cardiovascular ...
(Date:10/13/2017)... ... October 13, 2017 , ... Apple Rehab Shelton Lakes , ... mock evacuation of the facility as part of a disaster drill on October 3rd. ... EMS and Shelton City Emergency Manager, as well as the Connecticut Long Term ...
Breaking Medicine News(10 mins):
(Date:9/25/2017)... 2017  EpiVax, Inc., a leader in the ... today announced the launch of EpiVax Oncology Inc., ... therapeutic cancer vaccines. EpiVax has provided $500,000 in ... enabling technologies to the new precision immunotherapy venture. ... Oncology as Chief Executive Officer. Gad brings over ...
(Date:9/19/2017)... medical device company developing a non-invasive, robotically assisted, platform therapy that uses pulsed sound energy ... ... Jim Bertolina, PhD ... Tom Tefft ... executive Josh Stopek , PhD, who has led R&D and business development teams at ...
(Date:9/13/2017)... Sept. 13, 2017   OrthoAtlanta has been named ... Football Host Committee (AFHC) for the 2018 College Football Playoff ... 2018, at Mercedes-Benz Stadium in Atlanta, Georgia ... AFHC "I,m In" campaign, participating in many activities leading up ... ...
Breaking Medicine Technology: